New Brazilian Regulation Allows Passengers to Bring E-Cigarettes on Domestic Flights

Jul.23.2024

Brazil's National Civil Aviation Agency allows passengers to carry e-cigarette devices on domestic flights, but restricts international travel.

According to a report from Panrotas on July 22, the Brazilian National Civil Aviation Agency (Anac) recently authorized passengers to carry e-cigarette devices (DEF) on domestic flights, based on Resolution (RDC) No. 855/2024 issued by the Brazilian National Health Surveillance Agency (Anvisa). The resolution states that personal e-cigarette devices are not considered imported or transported goods on domestic flights. Therefore, as long as they are for personal use, e-cigarette devices can be carried as hand luggage on domestic flights.

Additionally, Anvisa has restricted flights departing from abroad from allowing passengers to bring e-cigarette devices into Brazil in their luggage. Therefore, e-cigarette devices cannot be transported as carry-on luggage (including for personal use) on international flights to Brazil.

References:

[1] Anac proíbe transporte de vape em voos internacionais e libera no doméstico

Also Read:

[1] Brazil's Crackdown on Illegal E-cigarette Trafficking: ELFBAR, OXBAR, IGNITE Included

[2] Federal Police Conduct Operation "Vapore" to Crackdown on E-cigarette Sales

[3] Brazil Senate Delays Vote on E-cigarette Regulation Legislation Again

[4] Brazilian Senate Committee to Vote on E-cigarette Sales Legislation

[5] Brazilian Federal Police Seize 1500 Smuggled E-cigarettes in Victoria City

#Legislation #Open system e-cigarettes #South America #Brazil

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

BAT acquires state-owned shares of UZBAT in Uzbekistan for $22.3 million

British American Tobacco (BAT) acquires state-owned shares of UZBAT, a joint venture in Uzbekistan, for $22.3 million.

Oct.15 by 2FIRSTS.ai

Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade

California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.

Nov.26 by 2FIRSTS.ai

Product | Magnetic-attach design + mini display: FASTA’s new product goes on sale in the U.S., priced around $16

FASTA’s 40K Kit hits U.S. retailers: magnetic prefilled pods + reusable battery, mini display, two power levels; rated 20 mL/40,000 puffs/50 mg; some listings at $15.99.